CUTR stock icon

Cutera
CUTR

$1.38
9.08%
 

About: Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.

Employees: 430

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 3 analysts
0
News positive %
of 7 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

12% less funds holding

Funds holding: 99 [Q4 2023] → 87 (-12) [Q1 2024]

20.16% less ownership

Funds ownership: 86.55% [Q4 2023] → 66.39% (-20.16%) [Q1 2024]

43% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 28

50% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 38

63% less call options, than puts

Call options by funds: $631K | Put options by funds: $1.68M

68% less capital invested

Capital invested by funds: $60.9M [Q4 2023] → $19.5M (-$41.5M) [Q1 2024]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q4 2023] → 0 (-1) [Q1 2024]

Research analyst outlook

3 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$3
117%
upside
Avg. target
$7.67
456%
upside
High target
$10
625%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Piper Sandler
Matt O'Brien
117%upside
$3
Neutral
Maintained
21 Jun 2024
Stephens & Co.
George Sellers
625%upside
$10
Overweight
Reiterated
22 Mar 2024
Stephens & Co.
George Sellers
625%upside
$10
Overweight
Reiterated
6 Mar 2024

Financial journalist opinion

Based on 7 articles about CUTR published over the past 30 days